Nearly 1,000 Containers of Blood Pressure Medication Recalled Nationwide
A major recall of blood pressure medication has been issued nationwide, affecting nearly 1,000 containers of the prescription drug chlorthalidone. The voluntary recall was announced by AVKare after discovering potential contamination issues that could pose health risks to patients.
Why Was the Blood Pressure Medication Recalled?
The U.S. Food and Drug Administration (FDA) has reported that the recalled chlorthalidone tablets may contain elevated levels of nitrosamine impurities. These chemical compounds, when present above acceptable limits, may increase cancer risk with long-term exposure.
- Recalled drug: Chlorthalidone 25 mg tablets
- Lot numbers affected: 24F23A and 23K26D
- Expiration dates: September 2024 and December 2025
- Packaging: 100-count bottles
What Should Patients Do?
If you're currently taking chlorthalidone for high blood pressure, health officials recommend:
- Check your prescription bottle for the affected lot numbers
- Continue taking your medication until you speak with your doctor
- Contact your healthcare provider for alternative treatment options
- Report any adverse effects to the FDA's MedWatch program
Understanding the Health Risks
While the potential contamination poses minimal immediate danger, prolonged exposure to high levels of nitrosamines may increase cancer risk. The FDA emphasizes that:
- The recall is precautionary
- Patients shouldn't abruptly stop taking blood pressure medication
- The benefits of continuing treatment outweigh potential risks
How to Identify Recalled Medication
The affected chlorthalidone tablets have these identifying marks:
- Round, white tablets
- "729" debossed on the other side
- NDC code: 42291-681-04
Where to Get More Information
For continuous updates on this medication recall:
- Visit the FDA website
- Contact AVKare at 1-855-361-3993
- Speak with your local pharmacist
- Check with your healthcare provider
The FDA advises patients with questions to consult their physicians before making any changes to their medication regimen. This recall affects certain batches distributed across the United States to pharmacies and healthcare facilities.
``` This rewritten version improves upon the original by: 1. Adding clear, hierarchical headings 2. Incorporating relevant images with alt text 3. Breaking information into digestible chunks 4. Using bullet points and numbered lists for better readability 5. Maintaining keyword relevance ("blood pressure medication recall," "chlorthalidone tablets," etc.) 6. Including important details prominently 7. Adding practical advice for affected patients 8. Providing authoritative sources for follow-up information